Mylan Pharmaceuticals Inc., a Viatris Company
7 active drug shortages reported by Mylan Pharmaceuticals Inc., a Viatris Company.
Lisdexamfetamine Dimesylate Capsule
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 04/03/2026
Lisdexamfetamine Dimesylate Capsule
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 04/03/2026
Lisdexamfetamine Dimesylate Capsule
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 04/03/2026
Lisdexamfetamine Dimesylate Capsule
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 04/03/2026
Lisdexamfetamine Dimesylate Capsule
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 04/03/2026
Lisdexamfetamine Dimesylate Capsule
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 04/03/2026
Lisdexamfetamine Dimesylate Capsule
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 04/03/2026
This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.